SOUTH SAN FRANCISCO, Calif., Sept. 29 MonogramBiosciences, Inc. (Nasdaq: MGRM) announced today that Alfred G. Merriweather,Senior Vice President and Chief Financial Officer, is scheduled to present acorporate overview at the JMP Securities' Third Annual Healthcare FocusConference on Tuesday, October 7 at 8:30 a.m. (Eastern Time) at Le ParkerMeridien Hotel in New York City.
To access the live audio broadcast or the subsequent archived recording,log on to http://www.monogrambio.com and go to the investor relations section("Investors/Media" tab) and click on the "Events & Webcasts" link provided onthe sidebar menu on the page.
About Monogram Biosciences, Inc.
Monogram is advancing individualized medicine by discovering, developingand marketing innovative products to guide and improve treatment of seriousinfectious diseases and cancer. The Company's products are designed to helpdoctors optimize treatment regimens for their patients that lead to betteroutcomes and reduced costs. The Company's technology is also being used bynumerous biopharmaceutical companies to develop new and improved antiviraltherapeutics and vaccines as well as targeted cancer therapeutics. Moreinformation about the Company and its technology can be found on its web siteat http://www.monogrambio.com.contacts: Alfred G. Merriweather Jeremiah Hall Chief Financial Officer Feinstein Kean Healthcare Tel: 650 624-4576 Tel: 415 677-2700 amerriweather@ jeremiah.hall@ monogrambio.com fkhealth.com
SOURCE Monogram Biosciences, Inc.